Aktionsplan Spectral AI Inc.
Erweiterter Zeitplan
Einfaches Diagramm
Über das Unternehmen
Spectral MD Holdings, Ltd., a predictive analytics company, develops AI algorithms and optical technology in wound care treatment. It offers DeepView wound imaging solution, an AI technology and multispectral imaging system that provides healing assessments for burn wounds and diabetic foot ulcers. Spectral MD Holdings, Ltd. was incorporated in 2020 and is headquartered in Dallas, Texas.
| IPO date |
2021-04-06 |
| ISIN |
US84757T1051 |
| Industry |
Health Care Equipment & Supplies |
| Sector |
Health Care |
| Валюта |
usd |
| Валюта отчета |
usd |
| Сайт |
https://www.spectral-ai.com
|
| Цена ао |
2.2 |
| Preisänderung pro Tag: |
+13.17% (2.43) |
| Preisänderung pro Woche: |
+45.5% (1.89) |
| Preisänderung pro Monat: |
+88.36% (1.46) |
| Preisänderung über 3 Monate: |
+127.27% (1.21) |
| Preisänderung über sechs Monate: |
+51.93% (1.81) |
| Preisänderung pro Jahr: |
+11.79% (2.46) |
| Preisänderung über 3 Jahre: |
-71.97% (9.81) |
| Preisänderung über 5 Jahre: |
0% (2.75) |
| Preisänderung über 10 Jahre: |
0% (2.75) |
| Preisänderung seit Jahresbeginn: |
+35.47% (2.03) |
|
|
Unterschätzung
| Name |
Bedeutung |
Grad |
| P/S |
1.91 |
7 |
| P/BV |
-20.2 |
0 |
| P/E |
0 |
0 |
| EV/EBITDA |
-7.33 |
0 |
| Gesamt: |
|
4.63 |
|
Effizienz
| Name |
Bedeutung |
Grad |
| ROA, % |
-195.04 |
0 |
| ROE, % |
1220.25 |
10 |
| Gesamt: |
|
3.33 |
|
|
|
Dividenden
| Name |
Bedeutung |
Grad |
| Div yield, % |
0 |
0 |
| DSI |
0 |
0 |
| Gesamt: |
|
0 |
|
Pflicht
| Name |
Bedeutung |
Grad |
| Debt/EBITDA |
-0.3047 |
10 |
| Gesamt: |
|
9.8 |
|
Wachstumsimpuls
| Name |
Bedeutung |
Grad |
| Rentabilität Revenue, % |
18.79 |
3 |
| Rentabilität Ebitda, % |
185.16 |
10 |
| Rentabilität EPS, % |
563.82 |
10 |
| Gesamt: |
|
6.6 |
|
| Aufsicht |
Berufsbezeichnung |
Zahlung |
Geburtsjahr |
| Mr. Wensheng Fan |
Co-Founder, Chief Innovation Strategist & Senior Advisor to the CEO |
978.63k |
1970 (55 Jahre) |
| Mr. Vincent Stanley Capone |
CFO, General Counsel & Corporate Secretary |
430.87k |
1967 (58 Jahre) |
| Ms. Christine Marks |
Vice President of Marketing & Commercialization |
349.32k |
|
| Prof. Paul Chadwick |
Executive Vice President of UK & EMEA |
N/A |
|
| Mr. Erich L. Spangenberg |
CEO of Health care & Director |
10k |
1962 (63 Jahr) |
| Mr. Stan Micek |
Interim Chief Operating Officer |
N/A |
|
| Mr. Jeremiah A. Sparks MBA |
Chief Commercialization Officer |
N/A |
|
| Mr. David Bronson |
Financial Controller |
N/A |
|
| Mr. Peter Martin Carlson CPA |
CEO & Director |
|
1964 (61 Jahr) |
